相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Innate Immune Tolerance and the Role of Kupffer Cells in Differential Responses to Interferon Therapy Among Patients With HCV Genotype 1 Infection
Daryl T. -Y. Lau et al.
GASTROENTEROLOGY (2013)
IFITM1 Is a Tight Junction Protein That Inhibits Hepatitis C Virus Entry
Courtney Wilkins et al.
HEPATOLOGY (2013)
Perspectives and challenges of interferon-free therapy for chronic hepatitis C
Christian M. Lange et al.
JOURNAL OF HEPATOLOGY (2013)
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus
Ludmila Prokunina-Olsson et al.
NATURE GENETICS (2013)
Class A Scavenger Receptor 1 (MSR1) Restricts Hepatitis C Virus Replication by Mediating Toll-like Receptor 3 Recognition of Viral RNAs Produced in Neighboring Cells
Hiromichi Dansako et al.
PLOS PATHOGENS (2013)
IL-1β Production through the NLRP3 Inflammasome by Hepatic Macrophages Links Hepatitis C Virus Infection with Liver Inflammation and Disease
Amina A. Negash et al.
PLOS PATHOGENS (2013)
Hepatitis C Virus Pathogen Associated Molecular Pattern (PAMP) Triggers Production of Lambda-Interferons by Human Plasmacytoid Dendritic Cells
Amy E. L. Stone et al.
PLOS PATHOGENS (2013)
The Mitochondrial Targeting Chaperone 14-3-3ε Regulates a RIG-I Translocon that Mediates Membrane Association and Innate Antiviral Immunity
Helene Minyi Liu et al.
CELL HOST & MICROBE (2012)
Hepatic Cell-Type Specific Gene Expression Better Predicts HCV Treatment Outcome Than IL28B Genotype
Ian McGilvray et al.
GASTROENTEROLOGY (2012)
HCV Infection Induces a Unique Hepatic Innate Immune Response Associated With Robust Production of Type III Interferons
Emmanuel Thomas et al.
GASTROENTEROLOGY (2012)
Association of gene expression involving innate immunity and genetic variation in interleukin 28B with antiviral response
Yasuhiro Asahina et al.
HEPATOLOGY (2012)
Identification of Type I and Type II Interferon-Induced Effectors Controlling Hepatitis C Virus Replication
Philippe Metz et al.
HEPATOLOGY (2012)
Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution
Lin Liu et al.
HEPATOLOGY (2012)
Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: Impaired viral kinetics and therapeutic response
Susanna Naggie et al.
HEPATOLOGY (2012)
Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates
Kui Li et al.
HEPATOLOGY (2012)
Antiviral strategies in hepatitis C virus infection
Christoph Sarrazin et al.
JOURNAL OF HEPATOLOGY (2012)
Control of Innate Immune Signaling and Membrane Targeting by the Hepatitis C Virus NS3/4A Protease Are Governed by the NS3 Helix α0
Stacy M. Horner et al.
JOURNAL OF VIROLOGY (2012)
Deciphering the Interleukin 28B Variants That Better Predict Response to Pegylated Interferon-α and Ribavirin Therapy in HCV/HIV-1 Coinfected Patients
Montserrat de Castellarnau et al.
PLOS ONE (2012)
Failure of innate and adaptive immune responses in controlling hepatitis C virus infection
Robert Thimme et al.
FEMS MICROBIOLOGY REVIEWS (2012)
Interferon-Induced Gene Expression Is a Stronger Predictor of Treatment Response Than IL28B Genotype in Patients With Hepatitis C
Michael T. Dill et al.
GASTROENTEROLOGY (2011)
Interferon lambdas: the next cytokine storm
Christabel Kelly et al.
GUT (2011)
Estimating the Net Contribution of Interleukin-28B Variation to Spontaneous Hepatitis C Virus Clearance
Julia di Iulio et al.
HEPATOLOGY (2011)
Interferon-β and Interferon-λ Signaling Is Not Affected by Interferon-Induced Refractoriness to Interferon-α In Vivo
Zuzanna Makowska et al.
HEPATOLOGY (2011)
Hepatitis C Virus Induces Interferon-λ and Interferon-Stimulated Genes in Primary Liver Cultures
Svetlana Marukian et al.
HEPATOLOGY (2011)
The Antiviral Protein Viperin Inhibits Hepatitis C Virus Replication via Interaction With Nonstructural Protein 5A
Karla J. Helbig et al.
HEPATOLOGY (2011)
DDX1, DDX21, and DHX36 Helicases Form a Complex with the Adaptor Molecule TRIF to Sense dsRNA in Dendritic Cells
Zhiqiang Zhang et al.
IMMUNITY (2011)
Interferon-lambda serum levels in hepatitis C
Bettina Langhans et al.
JOURNAL OF HEPATOLOGY (2011)
IFN-Induced TPR Protein IFIT3 Potentiates Antiviral Signaling by Bridging MAVS and TBK1
Xin-Yi Liu et al.
JOURNAL OF IMMUNOLOGY (2011)
Identification of the IFITM3 gene as an inhibitor of hepatitis C viral translation in a stable STAT1 cell line
L. Yao et al.
JOURNAL OF VIRAL HEPATITIS (2011)
Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus
K. Morikawa et al.
JOURNAL OF VIRAL HEPATITIS (2011)
ISG56 and IFITM1 Proteins Inhibit Hepatitis C Virus Replication
Amit Raychoudhuri et al.
JOURNAL OF VIROLOGY (2011)
Structural basis of RNA recognition and activation by innate immune receptor RIG-I
Fuguo Jiang et al.
NATURE (2011)
A diverse range of gene products are effectors of the type I interferon antiviral response
John W. Schoggins et al.
NATURE (2011)
IFIT1 is an antiviral protein that recognizes 5′-triphosphate RNA
Andreas Pichlmair et al.
NATURE IMMUNOLOGY (2011)
Genetic Variation of the IL-28B Promoter Affecting Gene Expression
Masaya Sugiyama et al.
PLOS ONE (2011)
Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus
Stacy M. Horner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Interferon-stimulated genes and their antiviral effector functions
John W. Schoggins et al.
CURRENT OPINION IN VIROLOGY (2011)
Distinct Patterns of IFITM-Mediated Restriction of Filoviruses, SARS Coronavirus, and Influenza A Virus
I-Chueh Huang et al.
PLOS PATHOGENS (2011)
Hepatitis C Virus Reveals a Novel Early Control in Acute Immune Response
Noella Arnaud et al.
PLOS PATHOGENS (2011)
Long-term persistent GBV-B infection and development of a chronic and progressive hepatitis C-like disease in marmosets
Yuki Iwasaki et al.
FRONTIERS IN MICROBIOLOGY (2011)
2′,5′-Oligoadenylate synthetase-like gene highly induced by hepatitis C virus infection in human liver is inhibitory to viral replication in vitro
Mariko Ishibashi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Peroxisomes Are Signaling Platforms for Antiviral Innate Immunity
Evelyn Dixit et al.
CELL (2010)
Variants in IL28B in Liver Recipients and Donors Correlate With Response to Peg-Interferon and Ribavirin Therapy for Recurrent Hepatitis C
Takasuke Fukuhara et al.
GASTROENTEROLOGY (2010)
Hepatic ISG Expression Is Associated With Genetic Variation in Interleukin 28B and the Outcome of IFN Therapy for Chronic Hepatitis C
Masao Honda et al.
GASTROENTEROLOGY (2010)
Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study
Andri Rauch et al.
GASTROENTEROLOGY (2010)
Cleavage of Mitochondrial Antiviral Signaling Protein in the Liver of Patients with Chronic Hepatitis C Correlates with a Reduced Activation of the Endogenous Interferon System
Pantxika Bellecave et al.
HEPATOLOGY (2010)
IL28B Genotype Is Associated With Differential Expression of Intrahepatic Interferon-Stimulated Genes in Patients With Chronic Hepatitis C
Thomas J. Urban et al.
HEPATOLOGY (2010)
Hepatitis C Virus Controls Interferon Production through PKR Activation
Noella Arnaud et al.
PLOS ONE (2010)
Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection
Ken Takahashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
IPS-1 Is Essential for the Control of West Nile Virus Infection and Immunity
Mehul S. Suthar et al.
PLOS PATHOGENS (2010)
Translational insensitivity to potent activation of PKR by HCV IRES RNA
Takashi Shimoike et al.
ANTIVIRAL RESEARCH (2009)
Hepatitis C Virus Blocks Interferon Effector Function by Inducing Protein Kinase R Phosphorylation
Urtzi Garaigorta et al.
CELL HOST & MICROBE (2009)
New Therapies for Hepatitis C Virus Infection
Vincent Soriano et al.
CLINICAL INFECTIOUS DISEASES (2009)
Innate immunity to virus infection
Osamu Takeuchi et al.
IMMUNOLOGICAL REVIEWS (2009)
The RNA-activated Protein Kinase Enhances the Induction of Interferon-β and Apoptosis Mediated by Cytoplasmic RNA Sensors
Christopher S. McAllister et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Intracellular Innate Immune Cascades and Interferon Defenses That Control Hepatitis C Virus
Stacy M. Horner et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2009)
MAVS Dimer Is a Crucial Signaling Component of Innate Immunity and the Target of Hepatitis C Virus NS3/4A Protease
Martin Baril et al.
JOURNAL OF VIROLOGY (2009)
Toll-Like Receptor 3 Mediates Establishment of an Antiviral State against Hepatitis C Virus in Hepatoma Cells
Nan Wang et al.
JOURNAL OF VIROLOGY (2009)
Nucleotide Sequences and Modifications That Determine RIG-I/RNA Binding and Signaling Activities
Dina Uzri et al.
JOURNAL OF VIROLOGY (2009)
The history of the natural history of hepatitis C (1968-2009)
Leonard B. Seeff
LIVER INTERNATIONAL (2009)
The global burden of hepatitis C
Daniel Lavanchy
LIVER INTERNATIONAL (2009)
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Dongliang Ge et al.
NATURE (2009)
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
David L. Thomas et al.
NATURE (2009)
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Vijayaprakash Suppiah et al.
NATURE GENETICS (2009)
Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Yasuhito Tanaka et al.
NATURE GENETICS (2009)
The Evolution of the Major Hepatitis C Genotypes Correlates with Clinical Response to Interferon Therapy
Phillip S. Pang et al.
PLOS ONE (2009)
The autophagy machinery is required to initiate hepatitis C virus replication
Marlene Dreux et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Interferon regulatory factor-3 activation, hepatic interferon-stimulated gene expression, and immune cell infiltration in hepatitis C virus patients
Daryl T. -Y. Lau et al.
HEPATOLOGY (2008)
Toll-like receptors and adaptor molecules in liver disease: Update
Ekihiro Seki et al.
HEPATOLOGY (2008)
Interleukin-29 Functions Cooperatively with Interferon to Induce Antiviral Gene Expression and Inhibit Hepatitis C Virus Replication
Nicole E. Pagliaccetti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA
Takeshi Saito et al.
NATURE (2008)
Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3-4A complex
Volker Brass et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Interferon signaling and treatment outcome in chronic hepatitis C
Magdalena Sarasin-Filipowicz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
IFN-lambda (IFN-λ) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo
Caroline Sommereyns et al.
PLOS PATHOGENS (2008)
Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus
Dong Jiang et al.
JOURNAL OF VIROLOGY (2008)
3 ' RNA elements in hepatitis C virus replication: Kissing partners and long poly(U)
Shihyun You et al.
JOURNAL OF VIROLOGY (2008)
Pretreatment sequence diversity differences in the full-length hepatitis C virus open reading frame correlate with early response to therapy
Maureen J. Donlin et al.
JOURNAL OF VIROLOGY (2007)
Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor
Yan Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity
Michaela U. Gack et al.
NATURE (2007)
Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2
Takeshi Saito et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS
Zihong Chen et al.
JOURNAL OF VIROLOGY (2007)
Interferons α and λ inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics
Tobias Marcello et al.
GASTROENTEROLOGY (2006)
Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication
Y. Itsui et al.
JOURNAL OF VIRAL HEPATITIS (2006)
Dissociation of a MAVS/IPS-1/VISA/Cardif-1KKε molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage
Rongtuan Lin et al.
JOURNAL OF VIROLOGY (2006)
Viral and therapeutic control of IFN-β promoter stimulator 1 during hepatitis C virus infection
YM Loo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity
XD Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus
E Meylan et al.
NATURE (2005)
Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF3
RB Seth et al.
CELL (2005)
Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector
KJ Helbig et al.
HEPATOLOGY (2005)
Adaptive immune responses in acute and chronic hepatitis C virus infection
DG Bowen et al.
NATURE (2005)
Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I
R Stumper et al.
JOURNAL OF VIROLOGY (2005)
Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling
E Foy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF
K Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Hepatitis C virus particles and lipoprotein metabolism
P André et al.
SEMINARS IN LIVER DISEASE (2005)
Regulation of hepatitis C virus replication by interferon regulatory factor 1
N Kanazawa et al.
JOURNAL OF VIROLOGY (2004)
Genetic diversity and evolution of hepatitis C virus - 15 years on
P Simmonds
JOURNAL OF GENERAL VIROLOGY (2004)
Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease
E Foy et al.
SCIENCE (2003)
Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication
CF Wang et al.
JOURNAL OF VIROLOGY (2003)
Genomic analysis of the host response to hepatitis C virus infection
AI Su et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Hepatitis C virus IRES-dependent translation is insensitive to an eIF2α-independent mechanism of inhibition by interferon in hepatocyte cell lines
G Koev et al.
VIROLOGY (2002)
Activation and evasion of the antiviral 2′-5′ oligoadenylate synthetase/ribonuclease L pathway by hepatitis C virus mRNA
JQ Han et al.
RNA (2002)
Treatment of acute hepatitis C with interferon alfa-2b
E Jaeckel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
